Resveratrol supplementation influences bone properties in the tibia of hindlimb-suspended mature fisher 344 × Brown norway male rats

Applied Physiology, Nutrition and Metabolism

Volumn 37, Issue 6, 2012, Pages 1179-1188

  Durbin, Stephanie M ^a   Jackson, Janna R ^a   Ryan, Michael J ^a   Gigliotti, Joseph C ^a   Alway, Stephen E ^a   Tou, Janet C ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Bone quality oxidative stress; Demineralization; Hindlimb suspension; Male rats; Resveratrol

Indexed keywords

CALCIUM; OSTEOCALCIN; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; BIOMECHANICS; BLOOD; BONE; BONE DENSITY; BROWN NORWAY RAT; DIET SUPPLEMENTATION; DRUG EFFECT; FISCHER 344 RAT; HINDLIMB; IMMOBILIZATION; MALE; METABOLIC BONE DISEASE; OSTEOPOROSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; RAT; TIBIA;

ABSORPTIOMETRY, PHOTON; ANIMALS; BIOMECHANICS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM; DIETARY SUPPLEMENTS; HINDLIMB; HINDLIMB SUSPENSION; MALE; OSTEOCALCIN; OSTEOPOROSIS; RATS; RATS, INBRED BN; RATS, INBRED F344; STILBENES; TIBIA;

EID: 84870228089     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/h2012-099     Document Type: Article

References (43)

1. Alarcón de la Lastra, C., and Villegas, I. 2005. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol. Nutr. Food Res. 49(5): 405-430. doi:10.1002/mnfr.200500022. PMID:15832402.
2. Alarcón de la Lastra, C.A., and Villegas, I. 2007. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 35(5): 1156-1160. doi:10.1042/BST0351156. PMID:17956300.
3. Armstrong, D., and Browne, R. 1994. The analysis of free radicals, lipid peroxidases, antioxidant enzymes and compounds related to oxidative stress as applied to the clinical chemistry laboratory. In Free radicals in diagnostic medicine: a systems approach to laboratory, technology, clinical correlations, and antioxidant therapy. Edited by D. Armstrong. Plenum Press, New York. pp. 43-58.
4. Bloomfield, S.A. 2010. Disuse osteopenia. Curr. Osteoporos. Rep. 8(2): 91-97. doi:10.1007/s11914-010-0013-4. PMID:20425616.
5. Bloomfield, S.A., Allen, M.R., Hogan, H.A., and Delp, M.D. 2002. Site- and compartment-specific changes in bone with hindlimb unloading in mature adult rats. Bone, 31(1): 149-157. doi: 10.1016/S8756-3282(02)00785-8. PMID:12110428.
6. Burns, J., Yokota, T., Ashihara, H., Lean, M.E., and Crozier, A. 2002. Plant foods and herbal sources of resveratrol. J. Agric. Food Chem. 50(11): 3337-3340. doi:10.1021/jf0112973. PMID:12010007.
7. Center for Disease Control. 2012. State physical activity statistics. Available from www.cdc.gov/physicalactivity/ [accessed March 2012].
8. Chachay, V.S., Kirkpatrick, C.M., Hickman, I.J., Ferguson, M., Prins, J.B., and Martin, J.H. 2011. Resveratrol - pills to replace a healthy diet? Br. J. Clin. Pharmacol. 72(1): 27-38. doi:10.1111/j.1365-2125.2011.03966.x. PMID:21410504.
9. Ebeling, P.R. 1998. Osteoporosis in men: new insights into aetiology, pathogenesis, prevention and management. Drugs Aging, 13(6): 421-434. doi:10.2165/00002512-199813060-00002. PMID:9883398.
10. Exponent. 2007. Dietary intake of resveratrol in the U.S. from naturally occurring food sources. Center for the Chemical Regulation and Food Safety, Washington, Report No. WD01138.000.
11. Fotiou, S., Fotiou, D., Alamanou, A., and Deliconstantinos, G. 2010. Resveratrol activation of nitric oxide synthase in rabbit brain synaptosomes: singlet oxygen (1O2) formation as a causative factor of neurotoxicity. In Vivo, 24(1): 49-53. PMID:20133975.
12. Garrett, I.R., Boyce, B.F., Oreffo, R.O., Bonewald, L., Poser, J., and Mundy, G.R. 1990. Oxygen-derived free radicals stimulate osteoclastic bone resorption in rodent bone in vitro and in vivo. J. Clin. Invest. 85(3): 632-639. doi:10.1172/JCI114485. PMID:2312718.
13. Giangregorio, L., and Blimkie, C.J. 2002. Skeletal adaptations to alterations in weight-bearing activity: a comparision of models of disuse osteoporosis. Sports Med. 32(7): 459-476. doi:10.2165/00007256-200232070-00005. PMID:12015807.
14. Habold, C., Momken, I., Ouadi, A., Bekaert, V., and Brasse, D. 2011. Effect of prior treatment with resveratrol on density and structure of rat long bones under tail-suspension. J. Bone Miner. Metab. 29(1): 15-22. doi:10.1007/s00774-010-0187-y. PMID:20458604.
15. Horton, J.A., Bariteau, J.T., Loomis, R.M., Strauss, J.A., and Damron, T.A. 2008. Ontogeny of skeletal maturation in the juvenile rat. Anat. Rec. (Hoboken), 291(3): 283-292. doi:10.1002/ar.20650. PMID:18228587.
16. Institute of Laboratory Animal Resources Commission on Life Sciences. 1996. Guide for the care and use of laboratory animals. National Academy Press, Washington, DC. pp. 21-55.
17. Ip, T.Y., Peterson, J., Byrner, R., and Tou, J.C. 2009. Bone responses to body weight and moderate treadmill exercising in growing male obese (fa/fa) and lean Zucker rats. J. Musculoskelet. Neuronal Interact. 9(3): 155-166. PMID:19724150.
18. Irshad, M., and Chaudhuri, P.S. 2002. Oxidant-antioxidant system: role and significance in human body. Indian J. Exp. Biol. 40(11): 1233-1239. PMID:13677624.
19. Juan, M.E., Vinardell, M.P., and Planas, J.M. 2002. The daily oral administration of high doses of trans-resveratrol to rats for 28 daysis not harmful. J. Nutr. 132(2): 257-260. PMID:11823587.
20. Juan, M.E., González-Pons, E., Munuera, T., Ballester, J., Rodríguez-Gil, J.E., and Planas, J.M. 2005. Trans-resveratrol, a natural antioxidant from grapes, increases sperm output in healthy rats. J. Nutr. 135(4): 757-760. PMID:15795430.
21. Kalantari, H., and Das, D.K. 2010. Physiological effects of resveratrol. Biofactors, 36(5): 401-406. doi:10.1002/biof.100. PMID: 20623511.
22. Lei, M., Liu, S.Q., and Liu, Y.L. 2008. Resveratrol protects bone marrow mesenchymal stem cell derived chondrocytes cultured on chitosan-gelatin scaffolds from the inhibitory effect of interleukin- 1beta. Acta Pharmacol. Sin. 29(11): 1350-1356. doi:10.1111/j.1745-7254.2008.00880.x. PMID:18954530.
23. Lorenzo, J. 2000. Interactions between immune and bone cells: new insights with many remaining questions. J. Clin. Invest. 106(6): 749-752. doi:10.1172/JCI11089. PMID:10995785.
24. Lukas, R., Gigliotti, J.C., Smith, B.J., Altman, S., and Tou, J.C. 2011. Consumption of different sources of omega-3 polyunsaturated fatty acids by growing female rats affects long bone mass and microarchitecture. Bone, 49(3): 455-462. doi:10.1016/j.bone.2011.05.029. PMID:21672645.
25. Momken, I., Stevens, L., Bergouignan, A., Desplanches, D., Rudwill, F., Chery, I., et al. 2011. Resveratrol prevents the wasting disorders of mechanical unloading by acting as a physical exercise mimetic in the rat. FASEB J. 25(10): 3646-3660. doi:10.1096/fj.10-177295. PMID:21715682.
26. Morey-Holton, E., Globus, R.K., Kaplansky, A., and Durnova, G. 2005. The hindlimb unloading rat model: literature overview, technique update and comparison with space flight data. Adv. Space Biol. Med. 10: 7-40. doi:10.1016/S1569-2574(05)10002-1. PMID:16101103.
27. Mundy, G.R. 2007. Osteoporosis and inflammation. Nutr. Rev. 65(12): S147-S151. doi:10.1301/nr.2007.dec.S147-S151. PMID: 18240539.
28. Norrdin, R.W., Jee, W.S., and High, W.B. 1990. The role of prostaglandins in bone in vivo. Prostaglandins Leukot. Essent. Fatty Acids, 41(3): 139-149. doi:10.1016/0952-3278(90)90081-U. PMID:2281118.
29. Ozgocmen, S., Kaya, H., Fadillioglu, E., Aydogan, R., and Yilmaz, Z. 2007. Role of antioxidant systems, lipid peroxidation, and nitric oxide in postmenopausal osteoporosis. Mol. Cell. Biochem. 295(1-2): 45-52. doi:10.1007/s11010-006-9270-z. PMID:16841180.
30. Parhami, F., Jackson, S.M., Tintut, Y., Le, V., Balucan, J.P., Territo, M., and Demer, L.L. 1999. Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J. Bone Miner. Res. 14(12): 2067-2078. doi:10.1359/jbmr.1999.14.12.2067. PMID:10620066.
31. Perrien, D.S., Akel, N.S., Dupont-Versteegden, E.E., Skinner, R.A., Siegel, E.R., Suva, L.J., and Gaddy, D. 2007. Aging alters the skeletal response to disuse in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292(2): R988-R996. doi:10.1152/ajpregu.00302.2006. PMID:17068163.
32. Pervaiz, S., and Holme, A.L. 2009. Resveratrol: its biologic targets and functional activity. Antioxid. Redox Signal. 11(11): 2851-2897. doi:10.1089/ars.2008.2412. PMID:19432534.
33. Petrovski, G., Gurusamy, N., and Das, D.K. 2011. Resveratrol in cardiovascular health and disease. Ann. N.Y. Acad. Sci. 1215(1): 22-33. doi:10.1111/j.1749-6632.2010.05843.x. PMID:21261638.
34. Rauch, F. 2005. Bone growth in length and width: the Yin and Yang of bone stability. J. Musculoskelet. Neuronal Interact. 5(3): 194-201. PMID:16172510.
35. Reagan-Shaw, S., Nihal, M., and Ahmad, N. 2008. Dose translation from animal to human studies revisited. FASEB J. 22(3): 659-661. doi:10.1096/fj.07-9574LSF. PMID:17942826.
36. Smith, B.J., Lucas, E.A., Turner, R.T., Evans, G.L., Lerner, M.R., Brackett, D.J., et al. 2005. Vitamin E provides protection for bone in mature hindlimb unloaded male rats. Calcif. Tissue Int. 76(4): 272-279. doi:10.1007/s00223-004-0269-8. PMID:15742232.
37. Teitelbaum, S.L. 2000. Bone resorption by osteoclasts. Science, 289(5484): 1504-1508. doi:10.1126/science.289.5484.1504. PMID:10968780.
38. Turner, R.T., Maran, A., Lotinun, S., Hefferan, T., Evans, G.L., Zhang, M., and Sibonga, J.D. 2001. Animal models for osteoporosis. Rev. Endocr. Metab. Disord. 2(1): 117-127. doi:10.1023/A:1010067326811. PMID:11704974.
39. Vico, L., Bourrin, S., Very, J.M., Radziszowska, M., Collet, P., and Alexandre, C. 1995. Bone changes in 6-mo-old rats after headdown suspension and a reambulation period. J. Appl. Physiol. 79(5): 1426-1433. PMID:8593997.
40. Wang, L., Banu, J., McMahan, C.A., and Kalu, D.N. 2001. Male rodent model of age-related bone loss in men. Bone, 29(2): 141-148. doi:10.1016/S8756-3282(01)00483-5. PMID:11502475.
41. Wenzel, E., Soldo, T., Erbersdobler, H., and Somoza, V. 2005. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res. 49(5): 482-494. doi: 10.1002/mnfr.200500003. PMID:15779067.
42. Williams, L.D., Burdock, G.A., Edwards, J.A., Beck, M., and Bausch, J. 2009. Safety studies conducted on high-purity transresveratrol in experimental animals. Food Chem. Toxicol. 47(9): 2170-2182. doi:10.1016/j.fct.2009.06.002. PMID:19505523.
43. Zhang, P., Hamamura, K., and Yokota, H. 2008. A brief review of bone adaptation to unloading. Genomics Proteomics Bioinformatics, 6(1): 4-7. doi:10.1016/S1672-0229(08)60016-9. PMID:18558381.